Amyloid Antibodies and the Role of the Geriatrician: Nate Chin, Sharon Brangman, and Jason Karlawish
GeriPal
AUGUST 17, 2023
There is a lot to digest with these draft clinical guidelines but the big change from the 2018 guideline is moving Alzheimers to a biological diagnosis (biomarker evidence only) not just for a research framework but now from a clinical one. The field of geriatrics has been, I would say, somewhat negative on these drugs. So I agree.
Let's personalize your content